Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr Reddy's Laboratories informs about press release

Date: 21-04-2023
Dr Reddy's Laboratories has informed that it enclosed a Press Release on ‘Dr. Reddy's Laboratories announces the launch of Treprostinil Injection in the US’.

The above information is a part of company’s filings submitted to BSE.